More Nanosonics Limited news
Nanosonics LimitedASX: NAN

Nanosonics receives FDA clearance for trophon2

Apr 26, 2018 at 10:55 PM EDT · Issued by Nanosonics Limited

Filed with ASX · Apr 26, 2018 at 10:55 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/nanosonics-receives-fda-clearance-for-trophon2

Watch Nanosonics' latest call↗Nanosonics (ASX:NAN) Q2 2026 Earnings Call · Replay · Feb 23Read the transcript of Nanosonics (ASX:NAN) Q2 2026 Earnings Call↗

Nanosonics Limited on 6ix

Story so far

  • Trophon EPR receives FDA clearance for the US marketMar 30, 2016
  • Nanosonics announces trophon EPR approval in JapanFeb 11, 2016
  • South Korean regulator approves trophon EPRFeb 11, 2016

Earlier from Nanosonics

  • 2018 Half Year Results Investor PresentationFeb 25, 2018
  • 2017 AGM Chairmans AddressNov 3, 2017
  • Nanosonics and GE Healthcare extend trophon relationshipAug 24, 2017
  • 2017 Full Year Results - Appendix 4EAug 23, 2017
  • Nanosonics expands into Japanese marketJun 15, 2017

Later from Nanosonics

  • Nanosonics receives Health Canada clearance for trophon2May 3, 2018
  • Nanosonics receives European CE Mark for trophon2Jun 27, 2018
  • 2018 Full Year Results - Appendix 4EAug 19, 2018
  • 2018 AGM Chairmans AddressNov 8, 2018
  • 2018 AGM PresentationNov 8, 2018
All Nanosonics news releases↗

Follow Nanosonics into a list and get an email when it puts out news.

Follow Nanosonics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer